Histopathologic features of Mycobacterium ulcerans infection, Emerg Infect Dis, vol.9, pp.651-656, 2003. ,
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study, Lancet Glob Health, vol.2, pp.70223-70225, 2014. ,
The pathology of Mycobacterium ulcerans infection, Pathology, vol.17, pp.594-600, 1985. ,
Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice, Infect Immun, vol.73, pp.6299-6310, 2005. ,
The location of Australian Buruli ulcer lesions-implications for unravelling disease transmission, PLoS Negl Trop Dis, vol.11, 2017. ,
Mycobacterium ulcerans infection, Lancet, vol.354, pp.1156-1159, 1999. ,
Buruli ulcer: a systemic disease, Clin Infect Dis, vol.37, pp.78-82, 2003. ,
, Epidemiology of Buruli ulcer infections, vol.24, pp.2011-2016, 1988.
Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient, Clin Exp Dermatol, vol.30, pp.649-651, 2005. ,
, , 2017.
, Mycobacterium ulcerans low infectious dose and mechanical transmission support insect bites and puncturing injuries in the spread of Buruli ulcer, PLoS Negl Trop Dis, vol.11
Aquatic insects as a vector for Mycobacterium ulcerans, Appl Environ Microbiol, vol.68, pp.4623-4628, 2002. ,
Human Mycobacterium ulcerans infections developing at sites of trauma to skin, Am J Trop Med Hyg, vol.23, pp.919-923, 1974. ,
Comparative genomics shows that Mycobacterium ulcerans migration and expansion preceded the rise of Buruli ulcer in southeastern Australia, Appl Environ Microbiol, vol.84, pp.2612-2629, 2018. ,
Mapping the global distribution of Buruli ulcer: a systematic review with evidence consensus, Lancet Glob Health, vol.7, issue.19, pp.30171-30179, 2019. ,
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer, Genome Res, vol.17, pp.192-200, 2007. ,
Aquatic plants stimulate the growth of and biofilm formation by Mycobacterium ulcerans in axenic culture and harbor these bacteria in the environment, Appl Environ Microbiol, vol.70, pp.1097-1103, 2004. ,
The incubation period of Buruli ulcer (Mycobacterium ulcerans infection) in Victoria, Australia -Remains similar despite changing geographic distribution of disease, PLoS Negl Trop Dis, vol.12, 2018. ,
The incubation period of Buruli ulcer (Mycobacterium ulcerans infection), PLoS Negl Trop Dis, vol.7, 2013. ,
Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease, Antimicrob Agents Chemother, vol.54, pp.3678-3685, 2010. ,
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial, Lancet, vol.375, pp.664-672, 2010. ,
Delayed versus standard assessment for excision surgery in patients with Buruli ulcer in Benin: a randomised controlled trial, Lancet Infect Dis, vol.18, issue.18, pp.30160-30169, 2018. ,
Buruli ulcer, a prototype for ecosystem-related infection, caused by Mycobacterium ulcerans, Clin Microbiol Rev, vol.31, pp.45-62, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01791637
A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice, Infect Immun, vol.75, pp.2642-2644, 2007. ,
BCGmediated protection against Mycobacterium ulcerans infection in the mouse, PLoS Negl Trop Dis, vol.5, p.985, 2011. ,
Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination, PLoS One, vol.7, 2012. ,
Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with Mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation, Am J Trop Med Hyg, vol.76, pp.132-134, 2007. ,
Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas, Clin Exp Immunol, vol.157, pp.271-281, 2009. ,
Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease, PLoS Negl Trop Dis, vol.8, 2014. ,
FVB/N mice spontaneously heal ulcerative lesions induced by Mycobacterium ulcerans and switch M. ulcerans into a low mycolactone producer, J Immunol, vol.196, pp.2690-2698, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01284881
Mycobacterium ulcerans mouse model refinement for pre-clinical profiling of vaccine candidates, PLoS One, vol.8, p.167059, 2016. ,
Transmission of Mycobacterium ulcerans to the nine-banded armadillo, Am J Trop Med Hyg, vol.61, pp.694-697, 1999. ,
Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer, Infect Immun, vol.69, pp.5403-5411, 2001. ,
Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting, 2008. ,
, PLoS Negl Trop Dis, vol.2, p.199
Vaccination with the surface proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans induces antibodies but fails to provide protection against Buruli ulcer, PLoS Negl Trop Dis, vol.10, 2016. ,
Immunogenicity and protection conferred by a recombinant Mycobacterium marinum vaccine against Buruli ulcer, Trials Vaccinol, vol.5, pp.88-91, 2016. ,
Recombinant BCG expressing Mycobacterium ulcerans Ag85A imparts enhanced protection against experimental Buruli ulcer, PLoS Negl Trop Dis, vol.9, 2015. ,
Overexpression of a Mycobacterium ulcerans Ag85B-EsxH fusion protein in recombinant BCG improves experimental Buruli ulcer vaccine efficacy, PLoS Negl Trop Dis, vol.10, p.5229, 2016. ,
Challenges and solutions for a rational vaccine design for TBendemic regions, Crit Rev Microbiol, vol.41, pp.389-398, 2015. ,
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence, Science, vol.283, pp.854-857, 1999. ,
Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4, Cell Death Dis, vol.9, 2018. ,
Mycolactone subverts immunity by selectively blocking the Sec61 translocon, J Exp Med, vol.213, pp.2885-2896, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01432024
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone, J Exp Med, vol.204, pp.1395-1403, 2007. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01402321
Proteomic analysis of polyketide and nonribosomal peptide biosynthesis, Curr Opin Chem Biol, vol.15, pp.48-56, 2011. ,
Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events, J Immunol, vol.184, pp.1436-1444, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00594632
The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function, J Immunol, vol.163, pp.3928-3935, 1999. ,
IFN-?-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone, J Immunol, vol.184, p.947, 2010. ,
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans, Proc Natl Acad Sci U S A, vol.101, pp.1345-1349, 2004. ,
Functional analysis and annotation of the virulence plasmid pMUM001 from Mycobacterium ulcerans, Microbiology, vol.151, pp.683-692, 2005. ,
Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice, PLoS Negl Trop Dis, vol.8, 2014. ,
Synthesis of Toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines, Methods Mol Biol, vol.494, pp.247-261, 2008. ,
Establishment of memory CD8 ? T cells with live attenuated influenza virus across different vaccination doses, J Gen Virol, vol.97, pp.3205-3214, 2016. ,
Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer, Microbes Infect, vol.8, pp.2075-2081, 2006. ,
Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model, PLoS Negl Trop Dis, vol.7, 2013. ,
Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice, Vaccine, vol.33, pp.2232-2239, 2015. ,
Antibody-mediated neutralization of the exotoxin mycolactone, the main virulence factor produced by Mycobacterium ulcerans, PLoS Negl Trop Dis, vol.10, 2016. ,
The cell wall-associated mycolactone polyketide synthases are necessary but not sufficient for mycolactone biosynthesis, PLoS One, vol.8, issue.70520, 2013. ,
Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics, PLoS Negl Trop Dis, vol.4, 2010. ,
Deciphering the genetic basis for polyketide variation among mycobacteria producing mycolactones, BMC Genomics, vol.9, p.462, 2008. ,
In-vitro activity of avermectins against Mycobacterium ulcerans, PLoS Negl Trop Dis, vol.9, 2015. ,
In vivo imaging of bioluminescent Mycobacterium ulcerans: a tool to refine the murine Buruli ulcer tail model, Am J Trop Med Hyg, vol.101, pp.1312-1321, 2019. ,
Support vector methods for survival analysis: a comparison between ranking and regression approaches, Artif Intell Med, vol.53, pp.107-118, 2011. ,
Hock immunization: a humane alternative to mouse footpad injections, J Immunol Methods, vol.328, pp.204-214, 2007. ,
Spontaneous healing of Mycobacterium ulcerans disease in Australian patients, PLoS Negl Trop Dis, vol.13, 2019. ,
Clinical features of spontaneous partial healing during Mycobacterium ulcerans infection, Open Forum Infect Dis, vol.3, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01281366
Spontaneous healing of Mycobacterium ulcerans lesions in the guinea pig model, PLoS Negl Trop Dis, vol.9, 2015. ,
Intranasal administration of the TLR2 agonist Pam 2 Cys provides rapid protection against influenza in mice, Mol Pharm, vol.9, pp.2710-2718, 2012. ,
Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam 2 Cys, Immunol Cell Biol, vol.94, pp.169-176, 2016. ,
Reducing the impact of influenza-associated secondary pneumococcal infections, Immunol Cell Biol, vol.94, pp.101-108, 2016. ,
Immune response to infection with Mycobacterium ulcerans, Infect Immun, vol.69, pp.1704-1707, 2001. ,
Application of Cox proportional hazards model in case of tuberculosis patients in selected Addis Ababa health centres, Ethiopia. Tuberc Res Treat, p.536976, 2014. ,
Survival analysis in infectious disease research: describing events in time, AIDS, vol.24, pp.2423-2431, 2010. ,
The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital, CMAJ, vol.184, pp.37-42, 2012. ,
Regulation of effector and memory CD8 T cell differentiation by IL-2-a balancing act, Front Immunol, vol.9, p.2987, 2018. ,
Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression, Infect Immun, vol.79, pp.421-430, 2011. ,
Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with Buruli ulcer disease, J Infect Dis, vol.200, pp.1675-1684, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01402286
The local immune response in ulcerative lesions of Buruli disease, Clin Exp Immunol, vol.143, pp.445-451, 2006. ,
Local activation of the innate immune system in Buruli ulcer lesions, J Invest Dermatol, vol.127, pp.638-645, 2007. ,
The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection, J Theor Biol, vol.252, pp.24-38, 2008. ,
Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis, Pulm Med, p.745483, 2012. ,
The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER, PLoS Pathog, vol.10, p.1004061, 2014. ,
Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection, Infect Immun, vol.75, pp.3979-3988, 2007. ,
Interferon-? is a crucial activator of early host immune defense against Mycobacterium ulcerans infection in mice, PLoS Negl Trop Dis, vol.10, 2016. ,
Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory response, Infect Immun, vol.74, pp.2917-2924, 2006. ,
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana, Clin Diagn Lab Immunol, vol.12, pp.125-129, 2005. ,
Immunology of tuberculosis, Annu Rev Immunol, vol.19, pp.93-129, 2001. ,
The emerging role of myeloid-derived suppressor cells in tuberculosis, Front Immunol, vol.10, p.917, 2019. ,
Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination, Front Immunol, vol.6, p.217, 2015. ,
Interleukin-17 and innate immunity in infections and chronic inflammation, J Autoimmun, vol.60, pp.1-11, 2015. ,
Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development, Eur J Immunol, vol.39, pp.2865-2876, 2009. ,
Interleukin-6 trans-signaling pathway promotes immunosuppressive myeloid-derived suppressor cells via suppression of suppressor of cytokine signaling 3 in breast cancer, Front Immunol, vol.8, p.1840, 2017. ,
Targeting IL-17 and TH17 cells in chronic inflammation, Nat Rev Drug Discov, vol.11, pp.763-776, 2012. ,
Indolent cutaneous ulceration due to infection with Mycobacterium ulcerans, Med J Aust, vol.41, pp.475-479, 1954. ,
Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo, Cell Microbiol, vol.7, pp.1295-1304, 2005. ,
Mycolactone-dependent depletion of endothelial cell thrombomodulin is strongly associated with fibrin deposition in Buruli ulcer lesions, PLoS Pathog, vol.11, 2015. ,
A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells, Infect Immun, vol.68, pp.877-883, 2000. ,
Identification using LC-MSn of co-metabolites in the biosynthesis of the polyketide toxin mycolactone by a clinical isolate of Mycobacterium ulcerans, Chem Commun (Camb), vol.22, pp.2822-2823, 2003. ,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, vol.227, pp.680-685, 1970. ,
PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8 ? T cell responses, Biomaterials, vol.137, pp.61-72, 2017. ,
Geometry of a TLR2-agonist-based adjuvant can affect the resulting antigen-specific immune response, Mol Pharm, vol.16, pp.2037-2047, 2019. ,
Soluble proteins induce strong CD8 ? T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2, J Immunol, vol.187, pp.1692-1701, 2011. ,
Rank-based inverse normal transformations are increasingly used, but are they merited?, Behav Genet, vol.39, pp.580-595, 2009. ,
Scikit-learn: machine learning in Python, J Mach Learn Res, vol.12, pp.2825-2830, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00650905
Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients, vol.5, p.2676, 1000. ,
Sparse kernel methods for high-dimensional survival data, Bioinformatics, vol.24, pp.1632-1638, 2008. ,
A support vector approach to censored targets, ICDM 2007: Proceedings of the Seventh IEEE International Conference on Data Mining, vol.28, 2007. ,
Visualizing data using t-SNE, J Mach Learn Res, vol.9, pp.2579-2605, 2008. ,
R: a language and environment for statistical computing, R Foundation for Statistical Computing, 2014. ,
Use of recombinant virus replicon particles for vaccination against Mycobacterium ulcerans disease, PLoS Negl Trop Dis, vol.9, 2015. ,
Homologous and heterologous immunity in infections of mice with Mycobacterium ulcerans and Mycobacterium balnei, Am Rev Tuberc, vol.76, pp.76-89, 1957. ,